Pediatric Oncology Experimental Therapeutics Investigators' Consortium
US
The Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC) is a specialized network of leading pediatric oncology centers focused on the early-phase clinical evaluation of innovative and experimental therapies for childhood cancers. By bringing together expert clinicians, researchers, and institutions, POETIC accelerates the development and testing of novel treatments, particularly for patients with relapsed or refractory cancers who have limited options. The network emphasizes collaboration and shared resources to design and conduct phase I and II clinical trials that aim to translate promising laboratory discoveries into effective therapies. Through this coordinated approach, POETIC plays a crucial role in expanding treatment possibilities and improving outcomes for children facing high-risk cancers.